Search

everythinglearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Tamsulosin can worsen sleep apnea in some patients.

Botulinum toxin injections effectively relieve pain from cutaneous leiomyomas.

The rs1128977 gene variant may affect cholesterol and body measurements.

The sensor accurately measures thallium ions in solutions with high selectivity.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Ritlecitinib is safe and may effectively treat alopecia areata.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Targeting PTEN can improve healing in venous leg ulcers.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.